Oligometastases: The new paradigm and options for radiotherapy: A critical review

Strahlentherapie und Onkologie

Volumn 189, Issue 5, 2013, Pages 357-363

  Badakhshi, H ^a   Grun A ^a   Stromberger, C ^a   Budach, V ^a   Boehmer, D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Curative options; Oligometastases; Oligometastatic state; Paradigm shift; Radiotherapy

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1;

BONE METASTASIS; BRACHYTHERAPY; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER SPECIFIC SURVIVAL; CANCER STEM CELL; CANCER SURGERY; CIRCULATING TUMOR CELL; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENOMIC INSTABILITY; HUMAN; LIVER METASTASIS; LUNG METASTASIS; METASTASIS; OLIGOMETASTASES; OVERALL SURVIVAL; PHENOTYPE; PROGRESSION FREE SURVIVAL; REVIEW; SPINE METASTASIS; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; THERAPY EFFECT;

HUMANS; NEOPLASM METASTASIS; RADIOTHERAPY; RADIOTHERAPY, IMAGE-GUIDED;

EID: 84877820905     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0326-1     Document Type: Review

References (60)

1. Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331(6024):1559-1564
2. Hellman S (1994) Karnofsky memorial lecture. Natural history of small breast cancers. J Clin Oncol 12(10):2229-2234
3. Fisher B (1980) Laboratory and clinical research in breast cancer - a personal adventure: the David A Karnovsky Memorial Lecture. Cancer Res 40:3863-3874
4. Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13:8-10
5. Gupta GP, Massagué J (2006) Cancer metastasis: building a Framework. Cell 127:679-695
6. Fielder IJ (2003) The pathogeneis of cancer metatsis: the "seed and soil" hypothesis revisited. Nat Rev Cancer 3:1-6
7. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57-70
8. Harris AL (2002) Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2(1):38-47
9. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10):721-732
10. Wong CC, Gilkes DM, Zhang H et al (2011) Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proc Natl Acad Sci U S A 108(39):16369-16374
11. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med 3(7):730-737
12. Al-Hajj M, Wicha MS, Benito-Hernandez A et al (2003) Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 100(7):3983-3988
13. Fang D, Nguyen TK, Leishear K et al (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65(20):9328-9337
14. Lorico A, Rappa G (2011) Phenotypic heterogeneity of breast cancer stem cells. J Oncol 2011:135039
15. Dewi DL, Ishii H, Kano Y et al (2011) Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges. J Gastroenterol 46(10):1145-1157
16. Cheng L, Alexander R, Zhang S et al (2011) The clinical and therapeutic implications of cancer stem cell biology. Expert Rev Anticancer Ther 11(7):1131-1143
17. Tang DG (2012) Understanding cancer stem cell heterogeneity and plasticity. Cell Res 22(3):457-472
18. Quail DF, Taylor MJ, Postovit LM (2012) Microenvironmental regulation of cancer stem cell phenotypes. Curr Stem Cell Res Ther 7(3):197-216
19. Clarke MF, Dick JE, Dirks PB et al (2006) Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66:9339-9344
20. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105-111
21. Quintana E, Shackleton M, Sabel MS et al (2008) Efficient tumour formation by single human melanoma cells. Nature 456(7222):593-598
22. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142
23. Mani SA, Guo W, Liao MJ et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704-715
24. Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7:415-428
25. Bekes EM, Schweighofer B, Kupriyanova TA et al (2011) Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am J Pathol 179(3):1455-1470
26. Weichselbaum RR, Hellman S (2011) Oligometastases revisited. Nat Rev Clin Oncol 8:378-382
27. D'Agostino GR, Autorino R, Pompucci A et al (2011) Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. Strahlenther Onkol 187(7):421-425
28. Scorsetti M, Mancosu P, Navarria P et al (2011) Stereotactic body radiation therapy (SBRT) for adrenal metastases: a feasibility study of advanced techniques with modulated photons and protons. Strahlenther Onkol 187(4):238-244
29. Holy R, Piroth M, Pinkawa M, Eble MJ (2011) Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer. Strahlenther Onkol 187(4):245-251
30. Rusthoven KE, Kavanagh BD, Burri SH et al (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 27:1579-1584
31. Ricke J, Mohnike K, Pech M et al (2010) Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 78:479-485
32. Milano MT, Zhang H, Metcalfe SK et al (2009) Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res Treat 115:601
33. Okunieff P, Petersen AL, Philip A et al (2006) Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol 45(7):808-817
34. Yoon SM, Choi EK, Lee SW et al (2006) Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumours. Acta Oncol 45:1108-1114
35. Ricardi U, Filippi AR, Guarneri A et al (2012) Stereotactic body radiation therapy for lung metastases. Lung Cancer 75(1):77-81
36. Pawlik TM, Scoggins CR, Zorzi D et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241(5):715-724
37. Mendez Romero A, Wunderink W, Hussain SM et al (2006) Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study. Acta Oncol 45:831-837
38. Rusthoven KE, Kavanagh BD, Cardenes H et al (2009) Multiinstitutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27(10):1572-1578
39. Fumagalli I, Bibault JE, Dewas S et al (2012) A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases. Radiat Oncol 7(1):164
40. Ricke J, Wust P (2011) Computed tomography-guided brachytherapy for liver cancer. Semin Radiat Oncol 21(4):287-293
41. Wieners G, Mohnike K, Peters N et al (2011) Treatment of hepatic metastases of breast cancer with CT-guided interstitial brachytherapy - a phase II-study. Radiother Oncol 100(2):314-319
42. Rades D, Kueter JD, Gliemroth J et al (2012) Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis. Strahlenther Onkol 188(2):143-147
43. Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665-1672
44. Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483-2491
45. Kocher M, Soffietti R, Abacioglu U et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29:134-141
46. Rades D, Hakim SG, Bajrovic A et al (2012) Impact of zoledronic acid on control of metastatic spinal cord compression. Strahlenther Onkol 188(10):910-916
47. Nguyen QN, Shiu AS, Rhines LD et al (2010) Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76:1185-1192
48. Gerszten PC, Burton SA, Ozhasoglu C et al (2007) Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine 32:193-199
49. Brown WT, Wu X, Fowler JF et al (2008) Lung metastases treated by CyberKnife image-guided robotic stereotactic radiosurgery at 41 months. South Med J 101:376-382
50. Norihisa Y, Nagata Y, Takayama K et al (2008) Stereotactic body radiotherapy for oligometastatic lung tumours. Int J Radiat Oncol Biol Phys 72:398-403
51. Lee MT, Kim JJ, Dinniwell R et al (2009) Phase I study of individualized stereotactic body radiotherapy of livermetastases. J Clin Oncol 27(10):1585-1591
52. Ambrosino G, Polistina F, Costantin G et al (2009) Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results. Anticancer Res 29:3381-3384
53. Herfarth KK, Debus J, Lohr F et al (2001) Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 19:164-170
54. Rule W, Timmerman R, Tong L et al (2011) Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases Ann Surg Oncol 18(4):1081-1087
55. Manon R, O'Neill A, Knisely J et al (2005) Eastern Cooperative Oncology Group. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol 23:8870-8876
56. Sanghavi SN, Miranpuri SS, Chappell R et al (2001) Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 51:426-434
57. Tsai JT, Lin JW, Chiu WT et al (2009) Assessment of image- guided CyberKnife radiosurgery for metastatic spine tumors. J Neuroncol 94:119-127
58. Yamada Y, Bilsky MH, Lovelock DM et al (2008) Highdose single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71:484-490
59. Gibbs IC, Kamnerdsupaphon P, Ryu MR et al (2007) Image-guided robotic radiosurgery for spinal metastases. Radiother Oncol 82:185-190
60. Ryu S, Fang Yin F, Rock J et al (2003) Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer 97:2013-2018